First Tracks Biotherapeutics (TRAX) CEO awarded 193,576 performance stock units

Rhea-AI Filing Summary

First Tracks Biotherapeutics, Inc. President and CEO Daniel Faga reported an acquisition of 193,576 performance stock units (PSUs), each representing a conditional right to receive one share of common stock. These PSUs were earned upon achievement of performance criteria certified on August 2, 2026, and vest 50% on August 2, 2027 and 50% on July 1, 2028, subject to his continued service. Following this award, Faga holds 387,156 PSUs in total.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Faga Daniel

Role President, CEO

Type	Security	Shares	Price	Value
Grant/Award	Performance Stock Units F1, F2, F3	193,576	$0.00	$0.00

Holdings After Transaction: Performance Stock Units — 387,156 shares (Direct)

Footnotes (3)

1. F1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on August 2, 2026.
2. F2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
3. F3. The PSUs vest and settle over two years; 50% vests on August 2, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.

Key Figures

Performance stock units granted: 193,576 units Total performance stock units after grant: 387,156 units First vesting tranche: 50% +1 more

4 metrics

Performance stock units granted 193,576 units Performance-based PSUs earned on August 2, 2026

Total performance stock units after grant 387,156 units Holdings of Daniel Faga following the reported transaction

First vesting tranche 50% PSUs vesting on August 2, 2027, subject to continued service

Second vesting tranche 50% PSUs vesting on July 1, 2028, subject to continued service

Key Terms

Performance Stock Units, restricted stock units, conditional right, vesting

4 terms

Performance Stock Units financial

"Represents performance-based restricted stock units ("PSUs") that were earned"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

restricted stock units financial

"Represents performance-based restricted stock units ("PSUs") that were earned"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

conditional right financial

"Each PSU represents a conditional right to receive one share"

vesting financial

"The PSUs vest and settle over two years; 50% vests on"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 06:25 PM Accepted by SEC EDGAR 08/05/2026 - 06:24 PM Learn about SEC filing dates

FAQ

What insider transaction did Daniel Faga report for TRAX on this Form 4?

Daniel Faga reported an acquisition of 193,576 performance stock units (PSUs). The units were earned after meeting performance criteria certified on August 2, 2026 and are settled in common stock upon vesting.

How many performance stock units does Daniel Faga hold in TRAX after this transaction?

After this transaction, Daniel Faga holds 387,156 performance stock units. This total reflects his PSU holdings following the grant of 193,576 PSUs reported in the filing.

What is the vesting schedule of the 193,576 PSUs granted to Daniel Faga at TRAX?

The 193,576 PSUs vest over two years: 50% on August 2, 2027 and 50% on July 1, 2028, subject to Daniel Faga’s continued service with the company on each vesting date.

What does each PSU reported by Daniel Faga in TRAX represent?

Each PSU reported represents a conditional right to receive one share of common stock of First Tracks Biotherapeutics, Inc. The PSUs convert into shares only upon satisfaction of vesting conditions.

Were the PSUs reported by Daniel Faga in TRAX performance-based awards?

Yes. The filing states these are performance-based restricted stock units (PSUs) that were earned after achieving specified performance criteria, which were certified by the Compensation Committee on August 2, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Faga Daniel

(Last) (First) (Middle)

10770 WATERIDGE CIRCLE, SUITE 210

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
First Tracks Biotherapeutics, Inc. [ TRAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units(1)	(2)	08/02/2026		A		193,576		(3)	(3)	Common Stock	193,576	$0	387,156	D

Explanation of Responses:

1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on August 2, 2026.

2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.

3. The PSUs vest and settle over two years; 50% vests on August 2, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.

	/s/ Ajim Tamboli, Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)